Skip to main content
. 2020 May 15;26:9. doi: 10.1186/s40885-020-00142-2

Table 4.

Odds ratios and 95% CI for hypertension of subjects according to quartiles of baseline WHtR in the cross-sectional and cohort studies

Odds ratio (95% CI)
Waist-to-height ratio
Quartile 1 Quartile 2 Quartile 3 Quartile 4
Men 0.38–0.47 0.47–0.51 0.51–0.54 0.54–0.74
Women 0.36–0.49 0.49–0.54 0.54–0.58 0.58–0.80
Cross-sectional study N = 1727 N = 432 N = 431 N = 432 N = 432 P-Value
Hypertension
 Incidence 202 (46.8%) 254 (58.9%) 312 (72.2%) 351 (81.3%) < 0.001
 Non-adjusted 1 1.63 (1.25–2.14) 2.96 (2.23–3.93) 4.93 (3.63–6.71) < 0.001
 Gender and age-adjusted 1 1.55 (1.17–2.05) 2.71 (2.02–3.63) 4.13 (3.01–5.67) < 0.001
 Multivariate-adjusted 1 1.44 (1.07–1.94) 2.35 (1.71–3.22) 3.44 (2.43–4.88) < 0.001
Cohort study N = 419 N = 170 N = 127 N = 79 N = 43 P-Value
Hypertension
 Incidence 27 (15.9%) 30 (23.6%) 24 (30.4%) 14 (32.6%) 0.022
 Non-adjusted 1 1.64 (0.92–2.93) 2.31 (1.23–4.35) 2.56 (1.20–5.46) 0.022
 Gender and age-adjusted 1 1.58 (0.88–2.83) 2.13 (1.12–4.04) 2.28 (1.04–5.00) 0.064
 Multivariate-adjusted 1 1.54 (0.82–2.92) 2.43 (1.18–5.03) 2.52 (1.03–6.20) 0.074

CI confidence interval. *Multivariate-adjusted for gender, age, smoking status, drinking status, exercise habits,presence of cardiovascular disease, triglycerides, HDL-cholesterol, LDL-cholesterol, use of antidyslipidemic medication, HbA1c, use of antidiabetic medication, eGFR, and serum uric acid. Bold values indicate significance (p < 0.05)